Skip to main content
Caplight Logo









BioTissue

BioTissue

Private
Miami, FloridaHealthcare & Life Scienceshttps://biotissue.com/

Last Round

Series C

Jun 26, 2019

Total Funding Raised

$117.25M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BioTissue is a biotechnology company that develops and commercializes regenerative medicine products derived from human amniotic membrane and umbilical cord tissues for ocular, surgical, and wound care applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

amniotic membraneocular surface diseaseregenerative medicinebiologic medical devicecorneal bandageocular surgerycryopreserved tissuebiologicsophthalmologyeye caretissue graftbiotechmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioTissue Comparables

Compare BioTissue with similar companies based on industry and business-model similarity.

BioTissue comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Merakris Therapeutics
85%
NuVision Biotherapies
83%
Surgenex
83%

BioTissue Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 26, 2019
Series BJun 23, 2015
DebtMay 12, 2015
Growth EquityAug 22, 2013

Key People

Founding team and executive leadership

Ted Davis

President & Chief Executive Officer

Executive Team

BioTissue Investors

Notable investors and investment history

BioTissue investors
InvestorRounds
EW Healthcare PartnersSeries C
Square 1 BankDebt
Ballast Point VenturesGrowth Equity, Series C, Series B
RC CapitalGrowth Equity, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 46% MoM.

  • Jan 23, 2026

    Acquiring surgical and wound care business for up to $40 million.

BioTissue Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioTissue Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioTissue's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range370
Year Founded1997
Last FundingJun 26, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?